RHEB and Alzheimer disease: Therefore, we conclude that the transduction of hippocampal neurons with Rheb(S16H) may have therapeutic potential against AD, and that further investigation of the clinical safety and feasibility of intrahippocampal administration of AAV1-Rheb(S16H) is warranted.